Ubrelvy (Ubrogepant) tablets 100mg

Quantity

Get it to United States within 10 working days with standard delivery.

Fast delivery to United States

Easy Returns & Exchanges

Ask About This Product

Condition : New

0

From UAE

To United States

in 5-10 days

Description

Ubrelvy (ubrogepant) is an oral medication used for the acute treatment of migraine attacks with or without aura in adults. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) receptor antagonists. Each tablet contains 100 mg of ubrogepant, which helps alleviate migraine symptoms by blocking the activity of CGRP, a protein involved in migraine pathophysiology.

How It Works

Ubrogepant works by selectively binding to and blocking the CGRP receptors in the brain. CGRP is a neuropeptide that plays a crucial role in the transmission of pain and the dilation of blood vessels during a migraine attack. By inhibiting the action of CGRP, ubrogepant reduces the pain and other symptoms associated with migraines, such as nausea, sensitivity to light, and sound.

Indications

  • Acute treatment of migraine with or without aura in adults

Contraindications

  • Known hypersensitivity to ubrogepant or any of its components
  • Concomitant use with strong CYP3A4 inhibitors

Side Effects

  • Nausea
  • Tiredness
  • Dry mouth
  • Drowsiness

Price in Different Countries

Country Price (per 100mg tablet) References
United States $90 GoodRx Ubrelvy Price
United Kingdom £70 NHS Ubrelvy Price
Canada $100 Canada Drugs Ubrelvy Price
Australia $95 PBS Ubrelvy Price
India ₹6,500 1mg Ubrelvy Price

Top 5 Global Brands

  • Ubrelvy (Allergan): The primary brand of ubrogepant used for the acute treatment of migraines.
  • Emgality (Eli Lilly and Company): A CGRP antagonist used for the preventive treatment of migraine in adults.
  • Ajovy (Teva Pharmaceuticals): Another CGRP antagonist indicated for the preventive treatment of migraine.
  • Nurtec ODT (Biohaven Pharmaceuticals): An orally disintegrating tablet for the acute treatment and preventive treatment of migraine.
  • Reyvow (Eli Lilly and Company): A serotonin (5-HT) 1F receptor agonist used for the acute treatment of migraine attacks.
Shopping Cart